LEADER 02239cam a2200517 a 4500001    9976534573506421
005    20231120143136.0
006    m     o  d f
007    cr b||||||||||
008    130624s1979    mdua    ob   f000 0 eng c
027    CAS No. 298-00-0
035    ocn849952787
035    (NjP)7653457-princetondb
035     |z(NjP)Voyager7653457
040    GPO |beng |cGPO |dGPO |dMvI
042    pcc
043    n-us---
049    DOCS
074    0507-G-12 (online)
086 0  HE 20.3159/2:157
088    NCI-CG-TR-157
090    Electronic Resource
245 00 Bioassay of methyl parathion for possible carcinogenicity / |cCarcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health.
264  1 Bethesda, Md. : |bU. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, |c1979.
300    1 online resource (x, 112 pages) : |billustrations.
336    text |btxt |2rdacontent
337    computer |bc |2rdamedia
338    online resource |bcr |2rdacarrier
490 1  National Cancer Institute carcinogenesis technical report series ; |vno. 157
490 1  DHEW publication ; |vno. (NIH) 79-1713.
500    Title from title screen (viewed on June 24, 2013).
500    "CAS, no. 298-00-0."
500    "NCI-CG-TR-157."
500    DHEW publication ; no. (NIH) 79-1713.
500    This bioassay of methyl parathion was conducted by the NCI Frederick Cancer Research Center (FCRC).
504    Includes bibliographical references (pages 37-38).
650  0 Carcinogens.
650  0 Parathion |xToxicology.
710 2  Frederick Cancer Research Center.
710 2  National Institutes of Health (U.S.)
710 2  Carcinogenesis Testing Program (U.S.)
776 08  |iPrint version:Frederick Cancer Research Center. |tBioassay of methyl parathion for possible carcinogenicity |w(OCoLC)14385841
830  0 National Cancer Institute carcinogenesis technical report series ; |vno. 157.
830  0 DHEW publication ; |vno. (NIH) 79-1713.
945    DOCS |cHE 20.3159/2:157
956 40  |uhttps://purl.fdlp.gov/GPO/gpo37702